These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 61963)

  • 61. Synergistic effect of antithrombin III, activated protein C and heparin on the inhibition of the tissue thromboplastin-mediated coagulation.
    Hirahara K; Etoh Y; Matsuishi T; Suzuki N; Kurata M
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):692-6. PubMed ID: 2752479
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A simple two-step isolation procedure for human and bovine antithrombin II/III (heparin cofactor): a comparison of two methods.
    Thaler E; Schmer G
    Br J Haematol; 1975 Oct; 31(2):233-43. PubMed ID: 53066
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of the molecular mass dependency of heparin stimulation of heparin cofactor II:thrombin interaction to antithrombin III:thrombin interaction.
    Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1987 May; 46(3):491-502. PubMed ID: 3603437
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Minimal heparin cofactor activity in disseminated intravascular coagulation and cirrhosis.
    Braunstein KM; Eurenius K
    Am J Clin Pathol; 1976 Sep; 66(3):488-94. PubMed ID: 60879
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells.
    Kaji T; Itoh F; Hayakawa Y; Oguma Y; Sakuragawa N
    Thromb Res; 1989 Oct; 56(1):99-107. PubMed ID: 2512688
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of prothrombinase by antithrombin-heparin at a macroscopic surface.
    Speijer H; Billy D; Willems G; Hemker HC; Lindhout T
    Thromb Haemost; 1995 Apr; 73(4):648-53. PubMed ID: 7495073
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evidence for an ester bond between thrombin and heparin cofactor.
    Owen WG; Penick GD; Yoder E; Poole BL
    Thromb Haemost; 1976 Feb; 35(1):87-95. PubMed ID: 60792
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma.
    Tollefsen DM; Majerus DW; Blank MK
    J Biol Chem; 1982 Mar; 257(5):2162-9. PubMed ID: 6895893
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.
    Wiggins RC
    J Biol Chem; 1983 Jul; 258(14):8963-70. PubMed ID: 6553057
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of protamine sulfate on antithrombin III activity.
    Matsuo T; Shanberge JN; Matsuo O
    Clin Chim Acta; 1983 Jul; 131(3):233-8. PubMed ID: 6883717
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of heparin on thrombin inactivation by antithrombin-III.
    Machovich R; Arányi P
    Biochem J; 1978 Sep; 173(3):869-75. PubMed ID: 708377
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Contact, coagulation and platelet interaction with heparin treated equipment during heart surgery.
    van der Kamp KW; van Oeveren W
    Int J Artif Organs; 1993 Dec; 16(12):836-42. PubMed ID: 8175200
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enzymatic inactivation of human antithrombin III. Limited proteolysis of the inhibitor by snake venom proteinases in the presence of heparin.
    Kress LF; Catanese J
    Biochim Biophys Acta; 1980 Sep; 615(1):178-86. PubMed ID: 7426659
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Heparin cofactor activity measured with an amidolytic method.
    Odegard OR; Lie M; Abildgaard U
    Thromb Res; 1975 Apr; 6(4):287-94. PubMed ID: 49087
    [No Abstract]   [Full Text] [Related]  

  • 76. Functional requirements for inhibition of thrombin by antithrombin III in the presence and absence of heparin.
    Tsiang M; Jain AK; Gibbs CS
    J Biol Chem; 1997 May; 272(18):12024-9. PubMed ID: 9115268
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevention of thrombus formation and growth by antithrombin III and heparin cofactor II-dependent thrombin inhibitors: importance of heparin cofactor II.
    Buchanan MR; Liao P; Smith LJ; Ofosu FA
    Thromb Res; 1994 Jun; 74(5):463-75. PubMed ID: 8085247
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The heparin-accelerated neutralisation of bovine alpha and beta thrombins by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1980 Sep; 632(1):131-7. PubMed ID: 7417517
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neutralization and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin-binding domain of S protein/vitronectin.
    Preissner KT; Müller-Berghaus G
    J Biol Chem; 1987 Sep; 262(25):12247-53. PubMed ID: 2442161
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A kinetic analysis of the interaction of human recombinant tissue factor pathway inhibitor with factor Xa utilizing and immunoassay and the effect of antithrombin III/heparin on the complex formation.
    Kamikubo Y; Hamuro T; Takemoto S; Nakahara Y; Kamei S; Nakagaki T; Miyamoto S; Funatsu A; Kato H
    Thromb Res; 1998 Feb; 89(4):179-86. PubMed ID: 9651145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.